Who owns the ARROW CLINICAL TRIALS trademark?

The ARROW CLINICAL TRIALS trademark is owned by Arrow Clinical Trials LLC.

What class is the ARROW CLINICAL TRIALS trademark registered in?

The ARROW CLINICAL TRIALS trademark is registered in Class 042 (Scientific, technology & SaaS services).

What is the serial number for ARROW CLINICAL TRIALS?

The USPTO serial number for ARROW CLINICAL TRIALS is 98382051.

What is the registration number for ARROW CLINICAL TRIALS?

ARROW CLINICAL TRIALS is registered under USPTO registration number 7718917.

ARR

USPTO Trademark Record

REGISTERED

ARROW CLINICAL TRIALS

SN 98382051·Reg 7718917·Filed Jan 30, 2024

Owner Arrow Clinical Trials LLC

Scientific and technological services and research and design relating thereto; industrial analysis, industrial research and industrial design services; quality control and authentication services; design and development of computer hardware and software.

ARROW CLINICAL TRIALS (Serial No. 98382051), Registration No. 7718917, is a registered US trademark filed on Jan 30, 2024 by Arrow Clinical Trials LLC. This trademark covers Class 042 (Scientific, technology & SaaS services).

early section 8: March 11, 2031

Mark Intelligence

ARROW CLINICAL TRIALS (Reg. #7718917) is a registered US trademark that has been protecting its owner, Arrow Clinical Trials LLC, since 2024. The mark covers Class 042 (Scientific, technology & SaaS services). Goods and services include Scientific and technological services and research and design relating thereto; industrial analysis, industrial research.... The mark faced 1 opposition proceeding during prosecution.

FILED

Jan 30, 2024

SERIAL

98382051

REG#

7718917

REGISTERED

Mar 11, 2025

Owner

Applicant

Arrow Clinical Trials LLC

Entity

LLC

State

Address

1717 N. Clyde Morris Boulevard, Ste 120, Daytona Beach, FL, 32117

Country

Attorney

NameLori Sandman

Law firm

Lori Sandman Sandman Law Office, PLLC

Address

125 Basin Street, Suite 206, Daytona Beach, FL 32114, United States

Get pre-filing clearance

AI attorney analyzes your proposed mark against USPTO — Go/No-Go verdict, class-by-class risks, and strategy recommendations.

Run clearance

Filing Information

StatusREGISTERED

Filing DateJan 30, 2024

Serial Number98382051

Registration No.7718917

Registration DateMar 11, 2025

Status DateMar 11, 2025

Published for OppositionJan 21, 2025

Mark TypeStandard characters

Status DescriptionLive and registered

Filing Signals

FILED

2024

YEARS AGO

CLASSES

MADRID FILINGS

—

Opposed 1× during prosecution

Search 15M+ trademarks

Free USPTO lookups by name, owner, or serial number. No account needed.

Search now

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 042Scientific, technology & SaaS services

US codes: 100, 101

First use anywhere: Sep 02, 2022

First use in commerce: Sep 02, 2022

This description is as filed with the USPTO and defines the scope of trademark protection.

Status History

18 events

REGISTERED-PRINCIPAL REGISTER

Mar 11, 2025

REGISTERED-PRINCIPAL REGISTER

NOTICE OF REGISTRATION CONFIRMATION EMAILED

Mar 11, 2025

NOTICE OF REGISTRATION CONFIRMATION EMAILED

PUBLISHED FOR OPPOSITION

Jan 21, 2025

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Jan 21, 2025

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Jan 15, 2025

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

APPROVED FOR PUB - PRINCIPAL REGISTER

Dec 21, 2024

APPROVED FOR PUB - PRINCIPAL REGISTER

TEAS PETITION TO REVIVE RECEIVED

Dec 11, 2024

TEAS PETITION TO REVIVE RECEIVED

PETITION TO REVIVE-GRANTED

Dec 11, 2024

PETITION TO REVIVE-GRANTED

NOTICE OF REVIVAL - E-MAILED

Dec 11, 2024

NOTICE OF REVIVAL - E-MAILED

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Dec 11, 2024

TEAS RESPONSE TO OFFICE ACTION RECEIVED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Dec 11, 2024

CORRESPONDENCE RECEIVED IN LAW OFFICE

TEAS/EMAIL CORRESPONDENCE ENTERED

Dec 11, 2024

TEAS/EMAIL CORRESPONDENCE ENTERED

NON-FINAL ACTION WRITTEN

Sep 03, 2024

NON-FINAL ACTION WRITTEN

NON-FINAL ACTION E-MAILED

Sep 03, 2024

NON-FINAL ACTION E-MAILED

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Sep 03, 2024

NOTIFICATION OF NON-FINAL ACTION E-MAILED

ASSIGNED TO EXAMINER

Aug 24, 2024

ASSIGNED TO EXAMINER

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

May 29, 2024

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

NEW APPLICATION ENTERED

Jan 30, 2024

NEW APPLICATION ENTERED

ARROW CLINICAL TRIALS

Get pre-filing clearance

Search 15M+ trademarks

Run a conflict check

Other Marks by Arrow Clinical Trials LLC

Other Marks in Class 042 — Scientific, technology & SaaS services

Other Marks by Lori Sandman

Resources

Company